Valuation: EQL Pharma AB

Market Cap 628M 65.59M 57M 53.22M 48.85M 92.12M 6.25B 93.72M 246M 3.12B 246M 241M 10.28B P/E 2027 *
44.3x
P/E 2028 * 9.98x
Enterprise Value 1.01B 106M 91.7M 85.61M 78.6M 148M 10.06B 151M 395M 5.02B 396M 388M 16.54B EV / Sales 2027 *
2.1x
EV / Sales 2028 * 1.64x
Free-Float
38.91%
Yield 2027 *
-
Yield 2028 * -
1 day-2.82%
Current month+1.47%
1 month-11.56%
3 months-56.80%
6 months-66.42%
Current year-64.27%
1 week 19.2
Extreme 19.2
21.65
1 month 19.2
Extreme 19.2
24.3
Current year 19.2
Extreme 19.2
67.5
1 year 19.2
Extreme 19.2
96.5
3 years 19.2
Extreme 19.2
98.6
5 years 19.2
Extreme 19.2
98.6
10 years 6.35
Extreme 6.35
98.6
Manager TitleAgeSince
Chief Executive Officer 40 2022-08-16
Director of Finance/CFO 51 2026-03-31
Chief Operating Officer 48 2022-08-16
Director TitleAgeSince
Chairman 61 2022-08-16
Chairman 59 -
Director/Board Member 53 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
12/30/25 Buy

Executive/Senior Manager

1,000 0.0034%
12/23/25 Buy

Chief Operating Officer

19,225 0.0651%
9/26/25 Buy

Executive/Senior Manager

1,000 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
-2.82%0.00%-78.49%-26.77% 65.59M
-1.51%+3.27%-21.47%-27.07% 16.19B
-0.69%+4.66%-26.88%-35.32% 7.45B
-2.58%-6.12%-23.94%-8.99% 6.26B
-0.09%+2.57%-6.20%-32.39% 4.08B
-0.36%+1.70%-20.33%-40.91% 3.32B
-1.86%-0.59%+6.20%-38.60% 3.12B
-0.70%+2.01%-41.76%-22.38% 3.1B
-2.33%-1.60%-12.61%+4.96% 2.64B
+3.24%-1.57%+100.74% - 2.58B
Average -0.98%+1.34%-12.48%-25.28% 4.88B
Weighted average by Cap. -1.09%+2.74%-13.91%-26.05%

Financials

2027 *2028 *
Net sales 480M 50.17M 43.6M 40.71M 37.37M 70.46M 4.78B 71.69M 188M 2.38B 188M 184M 7.87B 634M 66.27M 57.59M 53.77M 49.36M 93.07M 6.32B 94.69M 248M 3.15B 249M 243M 10.39B
Net income 14M 1.46M 1.27M 1.19M 1.09M 2.06M 139M 2.09M 5.48M 69.55M 5.5M 5.37M 229M 63M 6.58M 5.72M 5.34M 4.9M 9.25M 628M 9.41M 24.67M 313M 24.73M 24.19M 1.03B
Net Debt 382M 39.93M 34.7M 32.4M 29.74M 56.08M 3.81B 57.06M 150M 1.9B 150M 147M 6.26B 412M 43.06M 37.43M 34.94M 32.08M 60.48M 4.1B 61.54M 161M 2.05B 162M 158M 6.75B
Logo EQL Pharma AB
EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.
Employees
23
Date Price Change Volume
26-08-04 SEK 20.65 -2.82% 26,110
26-08-03 SEK 21.25 +4.42% 44,398
26-07-31 SEK 20.35 -1.45% 21,197
26-07-30 SEK 20.65 +2.74% 57,712
26-07-29 SEK 20.10 -2.66% 58,168
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise